StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$305.19+0.13 (+0.04%)

Close on Nov 18, 2026Market cap $8.52BP/E –Yield –

Praxis Precision Medicines operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Praxis Precision Medicines's operating income for the twelve months ending Jun 30, 2026 was -$378.17M. For fiscal 2025 it was -$326.20M. The highest annual figure on record is -$35.79M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$326.20M–
FY2024Dec 31, 2024-$200.17M–
FY2023Dec 31, 2023-$126.37M–
FY2022Dec 31, 2022-$214.99M–
FY2021Dec 31, 2021-$167.33M–
FY2020Dec 31, 2020-$61.97M–
FY2019Dec 31, 2019-$35.79M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$96.90M–
Q1 FY2026Mar 31, 2026-$105.86M–
Q4 FY2025Dec 31, 2025-$97.04M–
Q3 FY2025Sep 30, 2025-$78.36M–
Q2 FY2025Jun 30, 2025-$76.07M–
Q1 FY2025Mar 31, 2025-$74.73M–
Q4 FY2024Dec 31, 2024-$63.96M–
Q3 FY2024Sep 30, 2024-$56.84M–
Q2 FY2024Jun 30, 2024-$37.49M–
Q1 FY2024Mar 31, 2024-$41.89M–
Q4 FY2023Dec 31, 2023-$27.81M–
Q3 FY2023Sep 30, 2023-$25.52M–
Q2 FY2023Jun 30, 2023-$34.96M–
Q1 FY2023Mar 31, 2023-$38.09M–
Q4 FY2022Dec 31, 2022-$41.45M–
Q3 FY2022Sep 30, 2022-$44.29M–
Q2 FY2022Jun 30, 2022-$60.39M–
Q1 FY2022Mar 31, 2022-$68.85M–
Q4 FY2021Dec 31, 2021-$58.66M–
Q3 FY2021Sep 30, 2021-$44.77M–
Q2 FY2021Jun 30, 2021-$36.48M–
Q1 FY2021Mar 31, 2021-$27.42M–
Q4 FY2020Dec 31, 2020-$25.71M–
Q3 FY2020Sep 30, 2020-$16.22M–
Q2 FY2020Jun 30, 2020-$11.57M–
Q1 FY2020Mar 31, 2020-$8.47M–
Q4 FY2019Dec 31, 2019-$7.49M–
Q3 FY2019Sep 30, 2019-$10.65M–

More Praxis Precision Medicines figures

See a number that looks wrong?